EP1757283
Miðill til eflingar á æxliseyðandi áhrifum, æxliseyðandi miðill og aðferð til meðferðar á krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.6.2005EP published:
17.10.2012EP application number:
05745983.6
EP translation filed:
28.11.2012Grant published:
15.12.2012EPO information:
European Patent Register
Max expiry date:
1.6.2025Expiry date:
1.6.2021
Title:
ANTITUMOR EFFECT FORTIFIER, ANTITUMOR AGENT AND METHOD OF THERAPY FOR CANCER
Timeline
Today
2.6.2005EP application
17.10.2012EP Publication
28.11.2012Translation submitted
15.12.2012Registration published
1.6.2021Expires
Owner
Name:
TAIHO PHARMACEUTICAL CO., LTD.Address:
1-27, Kandanishiki-cho, Chiyoda-ku, 101-0054, Tokyo, JP
Inventor
Name:
KOIZUMI, Katsuhisac/o TAIHO PHARMACEUTICAL. CO., LTD.Address:
Tokushima-shi,Tokushima, JP
Name:
UCHIDA, Junjic/o TAIHO PHARMACEUTICAL. CO., LTD.Address:
Tokushima-shi,Tokushima, JP
Name:
TAKECHI, Teijic/o TAIHO PHARMACEUTICAL. CO., LTD.Address:
Tokushima-shi,Tokushima, JP
Name:
NUKATSUKA, Mamoruc/o TAIHO PHARMACEUTICAL. CO., LTD.Address:
Tokushima-shi,Tokushima, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2004171520Date:
9.6.2004Country:
JP
Classification
Categories:
A61K 31/132, A61K 31/4412, A61K 31/506, A61K 31/53, A61K 33/24, A61P 35/00, A61K 31/282
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 25.6.2013
Expires: 1.6.2014
Payer: Árnason Faktor
Number: 10
Paid: 26.5.2014
Expires: 1.6.2015
Payer: Árnason Faktor
Number: 11
Paid: 7.5.2015
Expires: 1.6.2016
Payer: Árnason Faktor
Number: 12
Paid: 10.5.2016
Expires: 1.6.2017
Payer: Árnason Faktor
Number: 13
Paid: 8.5.2017
Expires: 1.6.2018
Payer: Árnason Faktor
Number: 14
Paid: 14.5.2018
Expires: 1.6.2019
Payer: Árnason Faktor
Number: 15
Paid: 8.5.2019
Expires: 1.6.2020
Payer: Árnason Faktor
Number: 16
Paid: 5.5.2020
Expires: 1.6.2021
Payer: Árnason Faktor ehf.